U.S. drug distributor McKesson is planning to sell Canadian drugstore chain Rexall, The Globe and Mail reported on Thursday, citing sources familiar with the sales process. McKesson bought Rexall Health from Katz Group in 2016 to strengthen its position in Canada’s pharmaceutical supply chain. The deal was valued at about C$3 billion ($2.24 billion) at that time.
McKesson finding suitors for Canada’s Rexall Pharmacy – The Globe and Mail
Date:
More like thisRelated
Responsibility First, Not Position: BY Vijayendra on Speculation Over Second Term as BJP State Chief
Bengaluru: Amid speculation over his possible continuation as the...
Karnataka: Train Services Disrupted by Boulder Fall Near Yedakumari; Normalcy Restored by Morning
Bengaluru/Sakleshpur: Train operations on the South Western Railway route...
State Government’s Housing Quota for Minorities Aligned with Central Guidelines: CM Siddaramaiah Clarifies
“If this policy was unconstitutional or appeasement-based, why would the central government direct all states to implement it under schemes such as the Pradhan Mantri Awas Yojana?” Siddaramaiah questioned.
Karnataka Minister Priyank Kharge Seeks Explanation from MEA Over Denial of US Visit Clearance
Bengaluru/New Delhi: Karnataka’s Minister for Rural Development, Panchayat Raj...